Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy

Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum

(2012) Wei-Yu Liao et al.   Journal of Thoracic Oncology

Expression of ERCC1 predicts clinical outcome in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy

(2012) Pei-Yu Huang et al.   ORAL ONCOLOGY

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy

(2011) Shengxiang Ren et al.   LUNG CANCER

No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: A meta-analysis

(2010) Ming Yin et al.   LUNG CANCER

High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancer

(2010) Hyun Woo Lee et al.   ORAL ONCOLOGY

Treatment for metastatic nasopharyngeal carcinoma

(2010) Y. Bensouda et al.   European Annals of Otorhinolaryngology-Head and Neck Diseases

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms

(2009) B. B. Y. Ma et al.   ANNALS OF ONCOLOGY

The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma

(2009) Xiao-Dong Cheng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients

(2009) Tomoyoshi Takenaka et al.   LUNG CANCER

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients

(2009) A V Khrunin et al.   PHARMACOGENOMICS JOURNAL

Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review

(2008) J. Hopkins et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients

(2008) A. Woelfelschneider et al.   CARCINOGENESIS

Relationship BetweenERCC1Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer

(2008) Thomas C. Krivak et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

(2007) K.D. STEFFENSEN et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER